Pre-Annual General Meeting Information • Jun 24, 2024
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer

This year's Annual General Meeting will be held at The King's Fund, No. 11 Cavendish Square, London W1G 0AN on Thursday, 25 July 2024 at 12.30pm ('AGM')
This Notice of Meeting sets out the resolutions that shareholders are being asked to consider and vote on at the AGM of Halma plc (the 'Company'). The Board recognises the importance of the AGM to our investors and all shareholders are urged to vote, whether or not you plan to attend.
Shareholders are encouraged to appoint the Chair of the meeting as their proxy. It is recommended that shareholders submit their Proxy Form as early as possible to ensure that their votes are counted at the AGM.
If you are unable to attend the AGM in person, you can vote on the resolutions put to shareholders either online or by post as follows:
Online: if you have accessed this Notice of Meeting electronically or wish to vote online, go to www.investorcentre.co.uk/eproxy and follow the instructions.
By post: if you have received the Annual Report and Accounts 2024 or a notification that it is available to be viewed on the Company's website, you will also have received a Proxy Form. Instructions on voting can be found on the Proxy Form.
Please note that a printed copy of the Annual Report and Accounts 2024 will only be sent to you if you have opted to receive paper copies of such documents or if you have recently acquired shares.
Otherwise you may now access the Annual Report and Accounts 2024 by visiting our website at www.halma.com.
The AGM will be held at The King's Fund, No. 11 Cavendish Square, London W1G 0AN, shown on the map below. The meeting will commence at 12.30pm with doors opening from 12.00 noon.
Shareholders are invited to submit any questions regarding the formal business of the AGM via email to [email protected]. Any questions received by 12.30pm on 23 July 2024 will be grouped thematically and responses published on our website prior to the AGM. Any questions received after this date will be addressed either at the AGM, on the Company's website or in private correspondence.
The results of voting on all resolutions at the AGM will be released via a Regulatory Information Service and published on the Company's website as soon as possible after the AGM.
Should it become necessary to revise the current arrangements for the AGM, the Company will communicate any such changes to shareholders through a Regulatory Information Service and through the Company's website at www.halma.com.

If you are in any doubt as to the action you should take, you should consult your stockbroker, bank manager, solicitor, accountant or other independent adviser authorised under the Financial Services and Markets Act 2000.
If you have sold or otherwise transferred all your shares in the Company, you should send this document, together with the Proxy Form, as soon as possible to the purchaser or transferee, or to the stockbroker, bank or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee.
NOTICE IS HEREBY GIVEN that the Annual General Meeting of Halma plc will be held at The King's Fund, No. 11 Cavendish Square, London W1G 0AN on Thursday, 25 July 2024 at 12.30pm for the following purposes.
To consider and, if thought fit, pass resolutions 1 to 18 as ordinary resolutions and resolutions 19 to 22 as special resolutions:
(as such terms are defined in Part 14 of the 2006 Act) during the period beginning on the date of the passing of this resolution and ending on the earlier of (i) the conclusion of the annual general meeting of the Company to be held in 2025 and (ii) 30 September 2025, provided that the aggregate amount of all political donations and political expenditure made or incurred under paragraphs a., b. and c. above shall not exceed £100,000 in total.
and that this authority shall expire (unless previously renewed, revoked or varied by the Company in general meeting) when the authority conferred on the Directors in resolution 17 expires, save that the Company may make any offer or agreement before such expiry which would or might require equity securities to be allotted or equity securities held as treasury shares to be sold after such expiry and the Directors may allot equity securities and/or sell equity securities held as treasury shares in pursuance of such offer or agreement as if the power conferred by this resolution had not expired.
and that this authority shall expire (unless previously renewed, revoked or varied by the Company in general meeting) when the authority conferred on the Directors in resolution 17 expires, save that the Company may make any offer or agreement before such expiry which would or might require equity securities to be allotted or equity securities held as treasury shares to be sold after such expiry and the Directors may allot equity securities and/or sell equity securities held as treasury shares in pursuance of such offer or agreement as if the power conferred by this resolution had not expired.
and the authority hereby conferred shall expire (unless such authority is renewed by the Company in general meeting prior to such time) on the earlier of (i) the conclusion of the annual general meeting of the Company to be held in 2025 and (ii) 30 September 2025, save that the Company may before such expiry enter into a contract for the purchase of ordinary shares which would or might be completed wholly or partly after such expiry and the Company may purchase ordinary shares pursuant to any such contract as if this authority had not expired.
The Directors believe that each of the resolutions to be put to the meeting is in the best interests of the Company and its shareholders as a whole and unanimously recommend that shareholders vote in favour of them, as they intend to do in respect of their own beneficial shareholdings in the Company.
By order of the Board
Company Secretary
13 June 2024
Registered office: Halma plc Misbourne Court, Rectory Way Amersham, Buckinghamshire HP7 0DE
Registered in England and Wales No. 40932
Resolutions 1 to 18 will be proposed as ordinary resolutions which require a simple majority of the votes to be cast in favour of each resolution to be passed. Resolutions 19 to 22 will be proposed as special resolutions which require at least 75% of the votes to be cast in favour of each resolution to be passed.
The Directors are required by the 2006 Act to present the audited accounts of the Company to shareholders at a general meeting, together with reports of the Directors (including the Strategic Report) and the Auditor (in this case for the year ended 31 March 2024). As a matter of best practice, these are put to shareholders for approval.
This resolution seeks authority for the Company to pay a final dividend of 13.20p per share to shareholders for the financial year ended 31 March 2024, as recommended by the Directors. If approved, the dividend will be paid on 16 August 2024 to shareholders on the Register of Members at the close of business on 12 July 2024.
The Company offers a Dividend Reinvestment Plan ('DRIP') to enable shareholders to elect to have their cash dividends reinvested in Halma plc shares. Shareholders who wish to opt for the DRIP for the forthcoming final dividend, but have not already done so, should return a DRIP mandate form to the Company's Registrar no later than 26 July 2024.
Section 439 of the 2006 Act requires that the Remuneration Report is put to a vote of shareholders at each general meeting at which accounts of the Company are presented. The Remuneration Report is set out on pages 152 to 157 and 166 to 177 of the Annual Report and Accounts 2024. In accordance with the 2006 Act, the vote on this resolution is advisory and no remuneration is conditional on this resolution being passed.
The purpose of resolution 4, which is proposed as an ordinary resolution, is to invite shareholders to approve the Directors' Remuneration Policy (the 'Policy'). The vote on the Policy is a binding vote. If resolution 4 is passed, the Policy shall take effect immediately after the end of the AGM (the 'Effective Date'), meaning that from the Effective Date the Company may not make a remuneration payment or a payment for loss of office to a person who is, is to be, or has been a Director of the Company unless the payment is consistent with the Policy, or has been otherwise approved by shareholder resolution. If the Policy is not approved for any reason, the Company will, if and to the extent permitted by the 2006 Act, continue to make payments to Directors in accordance with the existing Policy and will seek shareholder approval for a further revised Policy as soon as is practicable.
If approved by shareholders, the Policy will be subject to a binding shareholder vote by ordinary resolution in a further three years (in accordance with the 2006 Act), except in the event that a change to the Policy is proposed or the advisory vote on the Remuneration Report is not passed in any year subsequent to the approval of the Policy.
As described in the Remuneration Report, the Remuneration Committee discussed the details of the Policy over a series of meetings, to assess whether the 2021 remuneration policy remains appropriate and relevant in the context of the Company's strategic plan and business goals set against a changing macro economic environment. With support from internal experts and external advisers, the Remuneration Committee concluded that the 2021 remuneration policy remains appropriate, so the overall structure remains unchanged from that policy. Only minor editorial amendments have been made for administrative reasons. The Policy is set out on pages 158 to 165 of the Annual Report and Accounts 2024.
The Company's Articles of Association require, and the UK Corporate Governance Code recommends, that each Director retire at the Annual General Meeting and seek re‑election.
All of the Directors seeking re‑election have been subject to a performance evaluation. Based on that evaluation, it is considered that each Director continues to be effective and demonstrates the level of commitment required in connection with their role and the needs of the business. The Board, on the recommendation of the Nomination Committee, supports the election and re‑election of each of the Directors.
It is the Board's view that each Director's contribution is, and continues to be, important to the Company's long‑term sustainable success, as described in each Director's biography set out below.
Independent non-executive Director A N R
Appointed: September 2023
Career and experience: Liam is Chief Executive of Johnson Matthey plc and brings a wealth of experience gained across a variety of roles, with a strong global background in driving growth and sustainability in the Life Science, Chemical and Energy Transition Industries. Earlier in his career, Liam held senior positions within Bayer AG and Schering AG.
Johnson Matthey plc, Chief Executive
Independent non-executive Director A N R
Career and experience: Giles has held a range of executive and non-executive positions across life sciences, technology and industrial businesses and brings extensive M&A and strategic business growth experience. His executive career included senior financial roles at Arthur Andersen (latterly as National Partner), Amersham plc (latterly as Group Finance Director) and as Finance Director at the University of Oxford. Since 2006, Giles has held a number of nonexecutive director roles including Elan Corporation, Victrex plc, BTG plc, Oxford University Innovation ltd, Oxford Sciences Innovation plc, Arix Bioscience plc, Senior plc and Abcam plc. He is currently Chair of PayPoint plc.
PayPoint plc, Chair

Appointed: February 2021 (July 2021 as Chair)
Career and experience: Louise is an experienced executive and board director, having led businesses across multiple sectors. She was the Chief Executive Officer of BTG plc, the international specialist healthcare company, from 2004 to 2019. Louise led the transformation of the company through a combination of organic growth and acquisitions, and significantly increased its market capitalisation before its sale in 2019. She previously served as a non-executive Director of Premier Foods plc, Woodford Patient Capital Trust plc and Intertek Group plc, and as a director of several not-for-profit organisations. Louise brings a wealth of leadership and international experience to the Board.
Group Chief Executive
Appointed: July 2018 (April 2023 as Group Chief Executive)
Career and experience: Marc was appointed Group Chief Executive in April 2023. He joined Halma in 2016 as Group Financial Controller and was promoted to the plc and Executive Board as Group CFO in July 2018. Marc brings a proven ability to drive business growth. He has played a vital role in evolving the Group's Sustainable Growth Model, purpose and culture, and has overseen a significant number of acquisitions while supporting Halma's companies to grow. Marc was previously the Finance Director of the UK operations of Wolseley plc (now Ferguson plc) and prior to that held various group and divisional roles at Inchcape plc.
Chief Financial Officer
Appointed: January 2023
Career and experience: Steve joined Halma in 2023 as Chief Financial Officer. He was previously CFO of International Airlines Group and prior to that held several senior commercial and finance roles within IAG, including CFO of British Airways and Chief Executive of IAG Cargo. Steve was also a non-executive Director at FirstGroup plc. Earlier in his career, Steve worked in range of finance and audit roles in the UK and US at PricewaterhouseCoopers.
Group Talent, Culture and Communications Director
Appointed: September 2016
Career and experience: Jennifer joined the Halma Executive Board in March 2014 and has global responsibility for talent and culture as well as internal and external communications and brand across Halma. Prior to joining Halma as Group Talent Director, Jennifer spent over 15 years leading Human Resources, Talent and Organisational Development for divisions of PayPal, Bank of America and Honeywell. Jennifer brings a wealth of experience to the Board to ensure we secure and develop talent ahead of our growth needs and build a sustainable culture of high performance.
Diploma plc, Non-executive director
Committee Membership
A Audit Committee N Nomination Committee R Remuneration Committee Chair of Committee Member of Committee
Independent non-executive Director

Appointed: January 2016
Career and experience: Carole was Chief Financial Officer of Aggreko plc until December 2017, prior to which she held a number of senior finance roles within that group. Previously, she worked at BAE Systems plc in a range of senior financial positions, which included four years in Australia. Carole commenced her career in the audit division of KPMG where she qualified as a Chartered Accountant. Carole has extensive financial experience and has a strong focus on governance and risk.
Forth Ports Limited, Chief Financial and Commercial Officer

Appointed: October 2016 (August 2023 as Senior Independent Director)
Career and experience: Jo has significant international experience, gained most recently as Corporate Vice President of the Phones Business Unit at Microsoft. She previously worked at Nokia as Executive Vice President of Smart Devices. Before her move into consumer electronics, Jo worked in strategic marketing at Reebok and Procter & Gamble. Jo brings a wealth of expertise to the Board in digital, technology, sales and marketing. She is Chair of the Remuneration Committee, and member of the Corporate Responsibility & Sustainability Committee, at J Sainsbury plc. Jo was previously Chair of the Remuneration Committee at InterContinental Hotels Group plc, and a Member of the Supervisory Board at Ceconomy AG.
J Sainsbury plc, Non-executive director Chapter Zero, Member of the Board Centrica plc, Non-executive director
Independent non-executive Director

Career and experience: Dharmash is an experienced technology venture capitalist, entrepreneur and nonexecutive director. He was formerly a Partner at Balderton & Lakestar, an executive at Emap PLC and worked earlier in his career at The Boston Consulting Group and as a Brand Manager at Procter & Gamble. Dharmash was formerly a founder of blow LTD, which he chaired, and has served as a non-executive director at The British Business Bank, BBC, Hargreaves Lansdown PLC and Dixons Retail PLC.
The Premier League, Non-executive director Rathbones Group plc, Non-executive director The FA, Non-executive director Competition & Markets Authority, Non-executive director
Independent non-executive Director

Career and experience: Sharmila brings extensive private and public sector experience from her executive and non-executive roles in health, media and sustainability. She began her career at PwC, qualifying as a Chartered Accountant, and served with the BBC for 15 years, latterly as Chief Operating Officer of BBC New Media, the division that built the iPlayer. Sharmila was Chief Executive of Wilton Park, an ambassador level role in the Foreign and Commonwealth Office, focused on topics such as global health, climate risk and national security. She has held executive board positions at the Medical Research Council, the Association of Medical Research Charities and the NHS and was appointed OBE for services to medical research.
ITV plc, Non-executive director Severn Trent plc, Non-executive director Coutts & Co, Non-executive director National Institute for Health and Care Excellence, Chair
The Company is required under the 2006 Act to appoint an auditor at every general meeting at which accounts are presented, to hold office until the conclusion of the next general meeting at which accounts are presented. The Directors are proposing the reappointment of PricewaterhouseCoopers LLP as the Company's Auditor. The proposal to re‑appoint PricewaterhouseCoopers LLP as the Company's Auditor is based on a recommendation from the Audit Committee, is free from third party influence and is not subject to any restrictive contractual arrangements.
In accordance with standard practice, this resolution gives authority to the Directors, acting through the Audit Committee, to determine the Auditor's remuneration for the next financial year.
The purpose of this resolution is to renew the Directors' authority to allot shares. This resolution would allow the Directors to allot shares and grant rights to subscribe for or convert any securities into shares up to an aggregate nominal value of £12,500,000, being just less than one third of the total issued share capital of the Company (excluding treasury shares) as at 13 June 2024 (being the latest practicable date prior to the publication of the Notice of Meeting). The Company currently does not hold any shares in treasury.
In accordance with the Directors' stated intention to seek annual renewal, the authority will expire on the earlier of (i) the conclusion of the annual general meeting of the Company in 2025 and (ii) 30 September 2025. Passing this resolution will give the Directors flexibility to act in the best interests of shareholders, when opportunities arise. The Directors have no current plans to make use of this authority.
Under the 2006 Act, political donations exceeding £5,000 in aggregate in any 12 month period to any political parties, independent election candidates or political organisations or the incurring of political expenditure are prohibited unless authorised by shareholders in advance. The Company does not, directly or through any subsidiary, make political donations or incur political expenditure within the ordinary meaning of those words and the Directors have no intention of using the authority for that purpose. The authority being requested from shareholders is not designed to change this. However, the definitions used in the 2006 Act are very broad and, as a result, it is possible that normal business activities (commonly accepted as a way of engaging with stakeholders to ensure that issues and concerns which are important to the Company are addressed) may be caught by the legislation. Activities of this nature are not designed to support any political party or to influence public support for a particular party. This resolution is proposed to ensure that the Company and its subsidiaries do not, because of any uncertainty due to the broad nature of the definitions under the 2006 Act, unintentionally commit any technical breach of the 2006 Act.
Resolutions 19 and 20, which will be proposed as special resolutions, would give the Directors the power to allot shares (or sell treasury shares) for cash, without first offering them to existing shareholders in proportion to their current holdings.
The power in resolution 19 would be limited (i) to allotments or sales under resolution 17 in connection with pre‑emptive offers; or (ii) otherwise to allotments or sales up to an aggregate nominal amount of £1,890,000 (representing 18,900,000 ordinary shares of 10 pence each), which represents approximately 5% of the Company's issued share capital as at 13 June 2024 (being the latest practicable date prior to the publication of the Notice of Meeting).
The effect of resolution 20 is to empower the Directors to disapply statutory pre‑emption rights in respect of an additional £1,890,000 (representing 18,900,000 ordinary shares of 10 pence each), which represents approximately 5% of the Company's issued share capital as at 13 June 2024 (being the latest practicable date prior to the publication of the Notice of Meeting).
In accordance with the Pre‑Emption Group's Principles, the Directors confirm that the power under resolution 20 will be used only in connection with an acquisition or specified capital investment that is announced contemporaneously with the issue, or that has taken place in the preceding 12‑month period and is disclosed in the announcement of the issue.
The Directors are aware of the Pre‑Emption Group's most recent Statement of Principles on Disapplying Pre‑emption Rights published in November 2022. However, at this time, the Directors consider it appropriate to retain the previous limits of 5% of the issued ordinary share capital of the Company in resolutions 19 and 20 and have not adopted the increased limits. The Directors will keep emerging market practice under review.
The powers in resolution 19 and resolution 20 will expire on the earlier of (i) the conclusion of the annual general meeting of the Company in 2025 and (ii) 30 September 2025.
The Director's confirm that they intend to follow the shareholder protections in paragraph one of Part 2B of the Statement of Principles on Disapplying Pre-Emption Rights, published by the Pre-Emption Group.
The Directors have no current plans to make use of these powers.
The Directors were authorised at the 2023 annual general meeting of the Company to purchase up to 37,900,000 of the Company's own 10p ordinary shares in the market. In accordance with the Directors' stated intention to seek annual renewal, this resolution (which will be proposed as a special resolution) will renew this authority until the earlier of (i) the conclusion of the annual general meeting of the Company in 2025 and (ii) 30 September 2025, in respect of up to 37,900,000 ordinary shares, which is approximately 10% of the Company's issued share capital as at 13 June 2024 (being the latest practicable date prior to the publication of the Notice of Meeting).
The Directors have no present intention of exercising the authority to make market purchases. However, the Directors consider it desirable that the possibility of making such purchases, under appropriate circumstances, is available. The Directors will only make purchases under the authority where they believe that to do so would result in an increase in earnings per share for the remaining shareholders or where the purchased shares are to be used to satisfy awards made under employee share plans, and such purchases are considered to be in the best interests of shareholders generally.
Any shares purchased under the authority would be either held as treasury shares or cancelled. The Company does not currently hold any shares in treasury or have any outstanding options or warrants.
Under the 2006 Act, the notice period for general meetings is 21 clear days' notice unless shareholders approve a shorter notice period, which cannot be less than 14 clear days. Annual general meetings must be held on at least 21 clear days' notice.
Resolution 22 seeks to renew the authority obtained at the 2023 annual general meeting of the Company allowing the Company to call general meetings (other than annual general meetings) on not less than 14 clear days' notice. It is intended that a shorter notice period will not be used as a matter of routine for general meetings, but only if the flexibility would be helpful given the business of the meeting and where the Board thinks it is in the interest of shareholders as a whole. If the resolution is passed, the authority will be effective until the annual general meeting of the Company in 2025, when it is intended that a similar resolution will be proposed.
The Company offers the facility for shareholders to vote and appoint proxies by electronic means. This is accessible to all shareholders and would be available if the Company were to call a meeting on 14 clear days' notice.
in each case so that it is received no later than 12.30pm on 23 July 2024 (or, in the event of any adjournment of the AGM, not less than 48 hours before the time fixed for the adjourned meeting, provided that no account shall be taken of any part of a day that is not a working day).
The statement of rights of shareholders in relation to the appointment of proxies in paragraphs 3 to 8 does not apply to Nominated Persons. The rights described in these paragraphs can only be exercised by shareholders of the Company.
If you have been nominated to receive general shareholder communications directly from the Company, it is important to remember that your main contact in terms of your investment remains as it was (the registered shareholder, or perhaps custodian or broker, who administers the investment on your behalf). Therefore any changes or queries relating to your personal details and holding (including any administration thereof) must continue to be directed to your existing contact at your investment manager or custodian. The Company cannot guarantee that we will be able to deal with matters that are directed to us in error. The only exception to this is where the Company, in exercising one of its powers under the 2006 Act, writes to you directly for a response.
determined by the timestamp applied to the message by the CREST Applications Host) from which the Company's agent is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST. After this time any change of instructions to proxies appointed through CREST should be communicated to the appointee through other means.
CREST members and, where applicable, their CREST sponsors or voting service providers, should note that Euroclear UK & Ireland Limited does not make available special procedures in CREST for any particular messages. Normal system timings and limitations will therefore apply in relation to the input of CREST Proxy Instructions. It is the responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member or sponsored member or has appointed a voting service provider, to procure that his / her CREST sponsor or voting service provider takes) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this connection, CREST members (and, where applicable, their CREST sponsors or voting service providers) are referred, in particular, to those sections of the CREST Manual concerning practical limitations of the CREST system and timings.
The Company may treat as invalid a CREST Proxy Instruction in the circumstances set out in Regulation 35(5)(a) of the Uncertificated Securities Regulations 2001.
The Company may require the shareholders requesting any such website publication to pay its expenses in complying with Sections 527 or 528 of the 2006 Act. Where the Company is required to place a statement on a website under Section 527 of the 2006 Act, it must forward the statement to the Company's Auditor not later than the time when it makes the statement available on the website. The business which may be dealt with at the AGM includes any statement that the Company has been required under Section 527 of the 2006 Act to publish on a website.
In addition, shareholders are invited to submit questions regarding the formal business of the meeting by email to [email protected] by 12.30pm on 23 July 2024. Shareholder questions will be grouped thematically and the responses made available on our website before the AGM. Any questions received after this date will be addressed either at the AGM, on the Company's website or in private correspondence.
20.The Company collects and processes information provided by or on behalf of shareholders. This information will include personal data such as names, contact details, votes cast, and any pre‑submitted questions. The Company may use this personal information for the purpose of compiling and updating its records, fulfilling its legal obligations, processing rights exercised by shareholders, answering questions and contacting shareholders with information relating to their shareholdings. The Company may also engage a third party to do this on its behalf (e.g. its Registrar, Computershare Investor Services PLC).
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.